RG

Regeneron Pharmaceuticals IncDUS Regeneron Stock Report

Last reporting period 30 Sep, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

113.4

Mega

Exchange

XDUS - Boerse Duesseldorf

View Full Company Analysis

Regeneron Cash and equivalents

9.8 B

Last period Cash and equivalents ,USD

267%

Cash and equivalents has increased in 5 years


What is Cash and equivalents ?

Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.

What is Cash and equivalents ?

Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.

What is Cash and equivalents of Regeneron ?

Regeneron`s Cash and equivalents for the period ended 2024-09-30 are 9.8 B USD

View Full Company Analysis